Jacobs Levy Equity Management, Inc Enanta Pharmaceuticals Inc Transaction History
Jacobs Levy Equity Management, Inc
- $25.8 Billion
- Q4 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 290,011 shares of ENTA stock, worth $1.83 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
290,011
Previous 191,726
51.26%
Holding current value
$1.83 Million
Previous $1.99 Million
16.15%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding ENTA
# of Institutions
108Shares Held
19.7MCall Options Held
9.7KPut Options Held
12.4K-
Krensavage Asset Management, LLC New York, NY2.12MShares$13.4 Million7.2% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.11MShares$13.3 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$12.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$11.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.22MShares$7.71 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $131M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...